title: The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation.
abstract: Th2 cytokine IL-5 and CC chemokine eotaxin are thought to be key regulators of eosinophils in bronchial asthma. However, their involvement in children with stable asthma (SA) has not been determined. We investigated the roles of IL-5 and eotaxin in eosinophil degranulation in children with SA. Induced sputum was obtained from 30 SA, 21 allergic rhinitis (AR), and 22 non-atopic healthy control (HC) children. We measured sputum levels of IL-5, eotaxin, and eosinophil indices [percentage eosinophils, eosinophil-derived neurotoxin (EDN), and eosinophil-cationic protein (ECP)]. We also examined correlations of IL-5 and eotaxin with eosinophil indices. Sputum percentage eosinophils and EDN and ECP levels were significantly higher in the SA group than in the HC group, while only the sputum EDN and ECP levels were significantly higher in the AR group than in the HC group. Unexpectedly, sputum levels of IL-5 were not significantly different among the three groups; however, the levels of eotaxin were higher in the SA group when compared to the HC group. No significant correlations were found between IL-5 and percentage eosinophils, EDN, or ECP levels; in contrast, eotaxin levels correlated significantly with percentage eosinophils (R(s) = 0.638; p = 0.0001), EDN (R(s) = 0.522; p = 0.003), and ECP levels (R(s) = 0.630 and p = 0.0002). The elevated levels and good correlations of eotaxin with sputum eosinophil indices, and no elevation or correlation of IL-5 with these indices, suggest that CC chemokine eotaxin may play a more important role in eosinophil degranulation in children with SA.
authors.affiliation: Pediatric Asthma and Allergy Center, Inje University Sanggye Paik Hospital, Seoul, Korea.
authors.forename: Chang K
authors.initials: CK
authors.lastname: Kim
authors.forename: Hirohito
authors.initials: H
authors.lastname: Kita
authors.forename: Zak
authors.initials: Z
authors.lastname: Callaway
authors.forename: Hyo B
authors.initials: HB
authors.lastname: Kim
authors.forename: Jungi
authors.initials: J
authors.lastname: Choi
authors.forename: Takao
authors.initials: T
authors.lastname: Fujisawa
authors.forename: Bo M
authors.initials: BM
authors.lastname: Shin
authors.forename: Young Y
authors.initials: YY
authors.lastname: Koh
mesh_terms: D000293:Adolescent; D001249:Asthma / Q000175:diagnosis / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D002452:Cell Count; D015550:Cell Degranulation / Q000276:immunology; D054413:Chemokine CCL11 / Q000276:immunology / Q000378:metabolism*; D002648:Child; D047150:Eosinophil Cationic Protein / Q000378:metabolism; D047208:Eosinophil-Derived Neurotoxin / Q000378:metabolism; D004804:Eosinophils / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D015848:Interleukin-5 / Q000276:immunology / Q000378:metabolism*; D008297:Male; D013183:Sputum / Q000378:metabolism; D018418:Th2 Cells / Q000276:immunology*
chemical_list: D054413:Chemokine CCL11; D015848:Interleukin-5; D047208:Eosinophil-Derived Neurotoxin; D047150:Eosinophil Cationic Protein
references.citation: Eur J Immunol. 1997 Dec;27(12):3507-16
references.pmid: 9464841
references.citation: J Clin Invest. 1999 Jan;103(2):175-83
references.pmid: 9916129
references.citation: Allergy. 1999 Jan;54(1):15-26
references.pmid: 10195355
references.citation: Am Rev Respir Dis. 1993 May;147(5):1126-31
references.pmid: 8484620
references.citation: J Immunol. 2002 Dec 1;169(11):6452-8
references.pmid: 12444154
references.citation: J Immunol. 1986 Apr 1;136(7):2348-57
references.pmid: 2419430
references.citation: Respirology. 2004 Nov;9(4):507-13
references.pmid: 15612963
references.citation: J Allergy Clin Immunol. 2000 Dec;106(6):1063-9
references.pmid: 11112887
references.citation: Respir Med. 2007 Jul;101(7):1447-54
references.pmid: 17379492
references.citation: Ann Allergy Asthma Immunol. 1999 May;82(5):491-6
references.pmid: 10353582
references.citation: Lancet. 2000 Dec 23-30;356(9248):2114-6
references.pmid: 11191533
references.citation: Annu Rev Immunol. 1989;7:145-73
references.pmid: 2523712
references.citation: N Engl J Med. 1990 Oct 11;323(15):1033-9
references.pmid: 2215562
references.citation: Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):308-17
references.pmid: 8756799
references.citation: Clin Mol Allergy. 2007 Oct 29;5:4
references.pmid: 17967188
references.citation: Bull Exp Biol Med. 2003 Apr;135(4):374-6
references.pmid: 12910312
references.citation: Allergy. 2000 Apr;55(4):392-7
references.pmid: 10782526
references.citation: Am Rev Respir Dis. 1993 Apr;147(4):901-7
references.pmid: 8466126
references.citation: Chest. 2008 Feb;133(2):412-9
references.pmid: 18252914
references.citation: J Exp Med. 1995 Oct 1;182(4):1169-74
references.pmid: 7561691
references.citation: Eur Respir J. 2007 Mar;29(3):489-95
references.pmid: 17079258
references.citation: Am J Respir Crit Care Med. 2003 Jan 15;167(2):199-204
references.pmid: 12406833
references.citation: J Exp Med. 1994 Mar 1;179(3):881-7
references.pmid: 7509365
references.citation: Clin Exp Allergy. 2001 Jan;31(1):69-76
references.pmid: 11167953
references.citation: Int Arch Allergy Immunol. 2003 Aug;131(4):283-90
references.pmid: 12915771
references.citation: Int Arch Allergy Immunol. 2001;125 Suppl 1:55-8
references.pmid: 11408775
references.citation: J Allergy Clin Immunol. 2000 Sep;106(3):507-13
references.pmid: 10984371
references.citation: Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):475-8
references.pmid: 10673188